(Q37165495)

18 August 2017

0 references

1 reference

title

Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability (English)

1 reference

18 August 2017

Bernard Bannwarth

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

31

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

485-503

1 reference

The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis

18 August 2017

cites work

1 reference

12 December 2020

Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction

1 reference

12 December 2020

Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug-induced hepatotoxicity

1 reference

12 December 2020

Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly

1 reference

12 December 2020

Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers

1 reference

12 December 2020

Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation

1 reference

12 December 2020

Value of epidemiologic studies in determining the true incidence of adverse events. The nonsteroidal anti-inflammatory drug story.

1 reference

12 December 2020

Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation

1 reference

12 December 2020

Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine

1 reference

12 December 2020

Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

12 December 2020

A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa.

1 reference

12 December 2020

A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen

1 reference

12 December 2020

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

12 December 2020

Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation

1 reference

12 December 2020

Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man

1 reference

12 December 2020

An overview of the long-term safety experience of nabumetone

1 reference

12 December 2020

A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and heart failure

1 reference

12 December 2020

Epidemiology of NSAID induced gastrointestinal complications.

1 reference

12 December 2020

Gastrointestinal safety profile of nabumetone: a meta-analysis

1 reference

12 December 2020

Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Worldwide safety experience with nabumetone

1 reference

12 December 2020

Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs and the small intestine

1 reference

12 December 2020

Safety evaluation of nabumetone in United States clinical trials

1 reference

12 December 2020

Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard

1 reference

12 December 2020

Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

Adverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tract

1 reference

12 December 2020

Treatment of elderly patients with nabumetone or diclofenac: gastrointestinal safety profile

1 reference

12 December 2020

Early pathogenic events in NSAID-induced gastrointestinal damage

1 reference

12 December 2020

Gastric ulcer formation and cyclo-oxygenase inhibition in cat antrum follows parenteral administration of aspirin but not salicylate

1 reference

12 December 2020

Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular events

1 reference

12 December 2020

An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis

1 reference

12 December 2020

Lumiracoxib in the management of osteoarthritis and acute pain

1 reference

12 December 2020

Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production

1 reference

12 December 2020

Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road

1 reference

12 December 2020

Tolerability and efficacy of nabumetone and naproxen in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

1 reference

12 December 2020

Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study

1 reference

12 December 2020

Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol

1 reference

12 December 2020

Nabumetone compared with naproxen in the treatment of rheumatoid arthritis: a multicenter, double blind, randomized, parallel group trial in hospital outpatients

1 reference

12 December 2020

Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

A decision analysis model in the evaluation of NSAIDs in a managed care setting: a case study

1 reference

12 December 2020

Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited

1 reference

12 December 2020

Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases

1 reference

12 December 2020

Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin

1 reference

12 December 2020

Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients

1 reference

12 December 2020

COX-2 selective inhibitors: analysis of the renal effects

1 reference

12 December 2020

Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety

1 reference

12 December 2020

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs and a selective cyclooxygenase 2 inhibitor uncouple mitochondria in intact cells

1 reference

12 December 2020

Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial

1 reference

12 December 2020

NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population

1 reference

12 December 2020

The unique pharmacologic profile of nabumetone

1 reference

12 December 2020

Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs)

1 reference

12 December 2020

Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?

1 reference

12 December 2020

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

The different patterns of blood pressure elevation by rofecoxib and nabumetone.

1 reference

12 December 2020

A population based historical cohort study of the mortality associated with nabumetone, Arthrotec, diclofenac, and naproxen

1 reference

12 December 2020

Do selective cyclo-oxygenase-2 inhibitors have a future?

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients

1 reference

12 December 2020

A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis

1 reference

12 December 2020

Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events

1 reference

12 December 2020

Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.

1 reference

12 December 2020

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach

1 reference

12 December 2020

Intestinal permeability and inflammation in patients on NSAIDs

1 reference

12 December 2020

Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs).

1 reference

12 December 2020

Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

1 reference

12 December 2020

Gastric mucus and bicarbonate secretion in relation to mucosal protection

1 reference

12 December 2020

A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group

1 reference

12 December 2020

Nabumetone compared with indomethacin in the treatment of osteoarthritis in general practice

1 reference

12 December 2020

The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function

1 reference

12 December 2020

Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin

1 reference

12 December 2020

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

12 December 2020

A microcomputer-assisted study of nabumetone and slow release diclofenac in osteoarthritis

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland

1 reference

12 December 2020

Lack of enterohepatic circulation of the active metabolite of nabumetone in humans

1 reference

12 December 2020

Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production

1 reference

12 December 2020

10.2165/00002018-200831060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

18 August 2017

1018258980

0 references

1 reference